
Regulatory & Compliance
Most Favored Nation Clauses in Private Fund Side Letters: Why Big LPs Get Them and Retail Investors Don't
Jeff Barnes, MBA··9 min read

Regulatory & Compliance
The $138 Million Warning: How One Adviser Sold Clients Funds He Secretly Controlled
Jeff Barnes, MBA··9 min read

Regulatory & Compliance
The SEC's New Retail Fraud Working Group Is a 2017 Rerun, and the Numbers Say Watch Closely
Jeff Barnes, MBA··10 min read

Regulatory & Compliance
Blue Origin's $10B Round Is Closed to You — Here's the Real Access Gap for Accredited Investors
Jeff Barnes, MBA··9 min read

Regulatory & Compliance
Regulation A+ Offerings Explained: The Accredited (and Non-Accredited) Investor Guide for 2026
Jeff Barnes, MBA··10 min read

Regulatory & Compliance
The Informed Investor Access Act: What Advisor-Verified Accreditation Really Changes
Jeff Barnes, MBA··10 min read

Regulatory & Compliance
Blocker Corporations: The Tax Insurance Policy Behind PE and VC Fund Structures
Jeff Barnes, MBA··10 min read

Regulatory & Compliance
UBTI and UBIT: The Hidden Tax Trap in Self-Directed IRA Alternative Investments
Jeff Barnes, MBA··10 min read

Regulatory & Compliance
What Is a Merger Sub? Inside the $4.5B Crinetics/Vertex Deal
Jeff Barnes, MBA··10 min read

Regulatory & Compliance
ESOPs as a Business Exit Vehicle: How Accredited Investors Can Fund the Transition
Jeff Barnes, MBA··10 min read

Regulatory & Compliance
SEC Rule 144A: The Institutional Safe Harbor Behind Your Private Credit Fund's Portfolio
Jeff Barnes, MBA··9 min read

Regulatory & Compliance
Morgan Stanley Drops the Accreditation Gate on PMAX: What 'Daily Subscriptions' Really Means
Jeff Barnes, MBA··10 min read